Engineered Microbes for Producing Anticholinergics

被引:1
作者
Courdavault, Vincent [1 ]
Cassereau, Julien [2 ]
Papon, Nicolas [3 ,4 ]
机构
[1] Univ Tours, Fac Pharm, EA2106 BBV, 31 Ave Monge, F-37200 Tours, France
[2] Univ Angers, MitoVasc Inst, INSERM 1083, MitoLab,CNRS,UMR 6015, Angers, France
[3] Univ Brest, Univ Angers, Host Pathogen Interact Study Grp GEIHP, EA 3142, Angers, France
[4] Univ Angers, Federat Struct Res Cellular Interact & Therapeut, SFR 4208 ICAT, Angers, France
关键词
anticholinergics; bioproduction; hyoscyamine dehydrogenase; tropane alkaloids; yeast;
D O I
10.1002/cbic.202000757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tropane alkaloids (TAs) hyoscyamine and scopolamine function as acetylcholine receptor antagonists and are used clinically as parasympatholytics to treat neuromuscular disorders in humans. While TAs are synthesized in a small subset of plant families, these specialized metabolites are only accumulated in limited quantities in plant organs. The complex chemical structures of these compounds make their industrial production by chemical synthesis very challenging, Therefore, the supply of these TAs still relies on intensive farming of Duboisia shrubs in tropical countries. Many adverse factors such as climate fluctuations and pandemics can thus influence annual world production. Based on the landmark microbial production of the antimalarial semi-synthetic artemisinin, the Smolke group recently developed a yeast cell factory capable of de novo synthesizing hyoscyamine and scopolamine, thus paving the way for an alternative production of these compounds.
引用
收藏
页码:1368 / 1370
页数:3
相关论文
共 50 条
  • [41] Using anticholinergics to treat overactive bladder: The issue of treatment tolerability
    Staskin, DR
    MacDiarmid, SA
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 : 9 - 15
  • [42] Mechanosensitive Channels in Microbes
    Kung, Ching
    Martinac, Boris
    Sukharev, Sergei
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, VOL 64, 2010, 2010, 64 : 313 - 329
  • [43] Dynamic adaptation of microbes
    Sonnleitner, B
    [J]. JOURNAL OF BIOTECHNOLOGY, 1998, 65 (01) : 47 - 60
  • [44] Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics - a European study
    Broekema, W. J.
    de Groot, I. W.
    van Harten, P. N.
    [J]. PHARMACY WORLD & SCIENCE, 2007, 29 (03): : 126 - 130
  • [45] Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
    W. J. Broekema
    I. W. de Groot
    P. N. van Harten
    [J]. Pharmacy World & Science, 2007, 29 : 126 - 130
  • [46] The concurrent use of anticholinergics and cholinesterase inhibitors: Rare event or common practice?
    Carnahan, RM
    Lund, BC
    Perry, PJ
    Chrischilles, EA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (12) : 2082 - 2087
  • [47] Antiparkinsonism anticholinergics increase dementia risk in patients with Parkinson's disease
    Hong, Chien-Tai
    Chan, Lung
    Wu, Dean
    Chen, Wan-Ting
    Chien, Li-Nien
    [J]. PARKINSONISM & RELATED DISORDERS, 2019, 65 : 224 - 229
  • [48] The role of anticholinergics in acute asthma treatment - An evidence-based evaluation
    Rodrigo, GJ
    Rodrigo, C
    [J]. CHEST, 2002, 121 (06) : 1977 - 1987
  • [49] HEREDITARY PARKINSONISM WITH MULTIPLE SYSTEM DEGENERATION - BENEFICIAL EFFECT OF ANTICHOLINERGICS, BUT NOT OF LEVODOPA
    MITSUI, T
    KAWAI, H
    SAKODA, S
    MIYATA, M
    SAITO, S
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1994, 125 (02) : 153 - 157
  • [50] Plant probiotic microbes - trending microbes for plant growth and value addition of compost - a review
    Aakash, R.
    Prabina, B. Jeberlin
    Gomathy, M.
    Ramesh, P. T.
    Hemalatha, M.
    [J]. PLANT SCIENCE TODAY, 2024, 11 (03): : 864 - 871